Submitted by admin on Fri, 09/13/2019 - 19:05 snippet Winning the advisory committee's backing is a major step toward approval, but experts pressed Aimmune with questions on the drug's safety. Source Biopharma Dive Headline Aimmune's peanut allergy drug secures FDA panel support, along with criticism News Tags Aimmune FDA peanut allergy advisory panel Palforzia AR 101